01 1Qingdao Biopeptek Co., Ltd.
02 1Qingdao Qinzeyuan Biotechnology Co., Ltd
01 2Larazotide
01 1U.S.A
02 1Blank
NDC Package Code : 73212-074
Start Marketing Date : 2023-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 85512-1045
Start Marketing Date : 2025-06-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
61
PharmaCompass offers a list of Larazotide Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Larazotide Acetate manufacturer or Larazotide Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Larazotide Acetate manufacturer or Larazotide Acetate supplier.
PharmaCompass also assists you with knowing the Larazotide Acetate API Price utilized in the formulation of products. Larazotide Acetate API Price is not always fixed or binding as the Larazotide Acetate Price is obtained through a variety of data sources. The Larazotide Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AT 1001 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AT 1001, including repackagers and relabelers. The FDA regulates AT 1001 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AT 1001 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AT 1001 supplier is an individual or a company that provides AT 1001 active pharmaceutical ingredient (API) or AT 1001 finished formulations upon request. The AT 1001 suppliers may include AT 1001 API manufacturers, exporters, distributors and traders.
click here to find a list of AT 1001 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AT 1001 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AT 1001 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AT 1001 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AT 1001 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AT 1001 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AT 1001 suppliers with NDC on PharmaCompass.
We have 1 companies offering AT 1001
Get in contact with the supplier of your choice:
